Blog Voices from the Frontlines
We are a nation in pain. The exact numbers are a matter of (contentious) debate, but somewhere between 11 and 30 percent of us are in chronic pain. Our backs hurt and our joints ache, we have irritable bowel syndrome and we get migraines on the regular.
The Department of Veterans Affairs is taking steps to remedy the problem of suicide in the veteran community. Dr. Nicole Braida is the Associate Chief of Staff for Mental Health at the South Texas VA. She says that over-prescription and misuse of opioid medication has created problems for the veteran community, leading to suicides and premature deaths.
At the recent Cannabis Science Conference, a “Docs and the Jocks” panel explored the role of cannabis in treating sports related injuries. Former NFL players Marvin Washington and Jim McMahon spoke about the stigma that remains present in the NFL towards those players who wish to treat their chronic pain with cannabis.
In the September 2017 Issue:
- Congress Extends Patient Protections to December
- DOJ Challenged by Congress on Cannabis Research Delays
- Maryland Approves Three More PFC-certified Companies
- PFC Trainings in Philly, New Webinar, California Conference
- ASA Educating State Officials at National Conference
- ASA Activist Profile: Valencia Elliott, Westchester, New York
- Action Alert: Sign the Petition on Ending the Opioid Crisis
There is a bottom line people lose sight of when discussing the opioid crisis sweeping the country: Millions of Americans experience chronic pain every day. They need help, and painkillers created using opioids are highly effective.
Study finds legal cannabis may reduce use of dangerous prescription drugs - Americans for Safe Access
“The potential for addiction and health risks associated with using multiple scheduled drugs places additional direct monetary and health costs on patients and healthcare systems due to an increased number of side effects, risky drug interactions, dependency, and overdose” stated University of New Mexico researchers Jacob Miguel Vigil and Sarah See Stith, of a new study titled, Effects of Legal Access to Cannabis on Scheduled II-V Drug Prescriptions, which will be soon released in an upcoming issue of the Journal of American Medical Directors Association.
The Princeton economist Alan Krueger started with a question: What’s keeping young people out of work? Over the last two decades, the share of employed Americans in their prime has steadily tumbled — even as the economy recovered and businesses nationwide struggled to fill openings. In a new paper, Krueger argues that opioids pose more than just a health threat: They’re benching workers across the country.
U.S. House Committee on Rules Blocks Rohrabacher-Blumenauer Amendment
Washington D.C. -- Last night, the House Committee on Rules voted to not allow a floor vote on an amendment which would continue to prevent the Department of Justice from using funds to interfere with state medical marijuana programs. The amendment, introduced by Representatives Dana Rohrabacher (R-CA) and Earl Blumenauer (D-OR) has been part of the appropriations package since 2015.
The success that medical cannabis has seen in the past five years has prompted researchers and scientists to dive deep into the plant’s medicinal properties and uses, one of the most important being the aid that cannabis can provide for victims of opioid addiction and chronic pain.
One in 12 doctors accepts payment from pharmaceutical companies related to opioids - Americans for Safe Access
One in twelve physicians - and nearly one in five family medicine physicians - accepted payments from pharmaceutical companies related to opioids, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine. This is the first large-scale, national study of industry payments involving opioids and suggests that pharmaceutical companies may have a stronger hold than previously known on how doctors prescribe the powerful drugs.